Ohio Public Employees Retirement System (OPERS)’s Dyne Therapeutics DYN Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2025
Q4
Sell
-33,100
Closed -$419K 2326
2025
Q3
$419K Buy
+33,100
New +$378K ﹤0.01% 1534
2023
Q3
Sell
-39,796
Closed -$448K 1976
2023
Q2
$448K Sell
39,796
-54,403
-58% -$642K ﹤0.01% 1293
2023
Q1
$1.08M Buy
94,199
+16,580
+21% +$215K ﹤0.01% 1142
2022
Q4
$900K Sell
77,619
-12,174
-14% -$141K ﹤0.01% 1188
2022
Q3
$1.14M Buy
+89,793
New +$1.03M 0.01% 1184

Other funds holding DYN

Ohio Public Employees Retirement System (OPERS)'s DYN Position: Q4 2025 in Review

Ohio Public Employees Retirement System (OPERS) sold out of Dyne Therapeutics (DYN) in Q4 2025, closing a stake of 33,100 shares — an estimated $419K sold.

Ohio Public Employees Retirement System (OPERS) first reported a position in DYN in Q3 2022 and held it in 5 quarters. The position peaked at $1.14M in Q3 2022. 232 funds tracked by Wall St. Rank hold DYN as of Q4 2025.

  • Ohio Public Employees Retirement System (OPERS) reported no remaining Dyne Therapeutics position as of Q4 2025 after selling out during the quarter.
  • Ohio Public Employees Retirement System (OPERS) sold 33,100 Dyne Therapeutics shares in Q4 2025, an estimated $419K.
  • Ohio Public Employees Retirement System (OPERS) first reported a position in Dyne Therapeutics in Q3 2022 and held it in 5 quarters.
  • Ohio Public Employees Retirement System (OPERS)'s Dyne Therapeutics position peaked at $1.14M in Q3 2022.
  • 232 funds tracked by Wall St. Rank held Dyne Therapeutics as of Q4 2025.

Based on Ohio Public Employees Retirement System (OPERS)'s 13F filing for Q4 2025, filed 17 Feb 2026.